Geron reported $-28618000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Amgen AMGN:US $ 3341M 185M
Bio Techne TECH:US $ 111.91M 18.1M
Cti Biopharma CTIC:US $ -34.78M 0.46M
Cytokinetics CYTK:US $ -76.52M 58.35M
Esperion Therapeutics ESPR:US $ -42836000 611K
Exelixis EXEL:US $ 87.73M 30.84M
Geron GERN:US $ -28.62M 2.3M
Gilead Sciences GILD:US $ 3422M 1947M
Macrogenics MGNX:US $ -63725000 8.44M
Novartis NOVN:VX SF 4552M 346M
Novavax NVAX:US $ 216.06M 1037.12M
Pain Therapeutics PTIE:US $ -17.51M 3.38M
Seattle Genetics SGEN:US $ -115.96M 37.85M
YTE INCY:US $ 144.1M 9.29M